The decrease in Healthcare-Associated methicillin-resistant Staphylococcus aureus infections and savings from glycopeptide use

Abstract

We evaluated changes in the rate of healthcare-associated methicillin-resistant Staphylococcus aureus ( MRSA) infections and healthcare-associated S. aureus infections after implementation of infection control precautions and the effect of this on glycopeptide use and expenditures for glycopeptides in a private medical center in Turkey in the years 2000-2005. A striking decrease was obtained in the number of MRSA infections, and the expenditure for glycopeptide use also decreased.